Lopes FM - Search Results

1

Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins.

Schönhofen P, de Medeiros LM, Bristot IJ, Lopes FM, De Bastiani MA, Kapczinski F, Crippa JA, Castro MA, Parsons RB, Klamt F. Schönhofen P, et al. Among authors: lopes fm. Mol Neurobiol. 2015 Aug;52(1):26-37. doi: 10.1007/s12035-014-8843-1. Epub 2014 Aug 10. Mol Neurobiol. 2015. PMID: 25108670

2

RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Lopes FM, da Motta LL, De Bastiani MA, Pfaffenseller B, Aguiar BW, de Souza LF, Zanatta G, Vargas DM, Schönhofen P, Londero GF, de Medeiros LM, Freire VN, Dafre AL, Castro MA, Parsons RB, Klamt F. Lopes FM, et al. Neurotox Res. 2017 May;31(4):545-559. doi: 10.1007/s12640-016-9699-0. Epub 2017 Feb 2. Neurotox Res. 2017. PMID: 28155214 Free article.

3

In vitro optimization of retinoic acid-induced neuritogenesis and TH endogenous expression in human SH-SY5Y neuroblastoma cells by the antioxidant Trolox.

da Frota Junior ML, Pires AS, Zeidán-Chuliá F, Bristot IJ, Lopes FM, de Bittencourt Pasquali MA, Zanotto-Filho A, Behr GA, Klamt F, Gelain DP, Moreira JC. da Frota Junior ML, et al. Among authors: lopes fm. Mol Cell Biochem. 2011 Dec;358(1-2):325-34. doi: 10.1007/s11010-011-0983-2. Epub 2011 Jul 7. Mol Cell Biochem. 2011. PMID: 21735090

4

Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.

Lopes FM, Schröder R, da Frota ML Jr, Zanotto-Filho A, Müller CB, Pires AS, Meurer RT, Colpo GD, Gelain DP, Kapczinski F, Moreira JC, Fernandes Mda C, Klamt F. Lopes FM, et al. Brain Res. 2010 Jun 14;1337:85-94. doi: 10.1016/j.brainres.2010.03.102. Epub 2010 Apr 7. Brain Res. 2010. PMID: 20380819

5

Evaluation of the neurotoxic/neuroprotective role of organoselenides using differentiated human neuroblastoma SH-SY5Y cell line challenged with 6-hydroxydopamine.

Lopes FM, Londero GF, de Medeiros LM, da Motta LL, Behr GA, de Oliveira VA, Ibrahim M, Moreira JC, Porciúncula LO, da Rocha JB, Klamt F. Lopes FM, et al. Neurotox Res. 2012 Aug;22(2):138-49. doi: 10.1007/s12640-012-9311-1. Epub 2012 Jan 20. Neurotox Res. 2012. PMID: 22271527

6

In vitro evaluation of antitumoral efficacy of catalase in combination with traditional chemotherapeutic drugs against human lung adenocarcinoma cells.

de Oliveira VA, da Motta LL, De Bastiani MA, Lopes FM, Müller CB, Gabiatti BP, França FS, Castro MA, Klamt F. de Oliveira VA, et al. Among authors: lopes fm. Tumour Biol. 2016 Aug;37(8):10775-84. doi: 10.1007/s13277-016-4973-6. Epub 2016 Feb 12. Tumour Biol. 2016. PMID: 26873489

7

Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models.

Lopes FM, Bristot IJ, da Motta LL, Parsons RB, Klamt F. Lopes FM, et al. Neuromolecular Med. 2017 Sep;19(2-3):241-255. doi: 10.1007/s12017-017-8454-x. Epub 2017 Jul 18. Neuromolecular Med. 2017. PMID: 28721669 Review.

8

Methylglyoxal-Induced Protection Response and Toxicity: Role of Glutathione Reductase and Thioredoxin Systems.

Schmitz AE, de Souza LF, Dos Santos B, Maher P, Lopes FM, Londero GF, Klamt F, Dafre AL. Schmitz AE, et al. Among authors: lopes fm. Neurotox Res. 2017 Oct;32(3):340-350. doi: 10.1007/s12640-017-9738-5. Epub 2017 May 6. Neurotox Res. 2017. PMID: 28478530

9

CFL1 expression levels as a prognostic and drug resistance marker in nonsmall cell lung cancer.

Castro MA, Dal-Pizzol F, Zdanov S, Soares M, Müller CB, Lopes FM, Zanotto-Filho A, da Cruz Fernandes M, Moreira JC, Shacter E, Klamt F. Castro MA, et al. Among authors: lopes fm. Cancer. 2010 Aug 1;116(15):3645-55. doi: 10.1002/cncr.25125. Cancer. 2010. PMID: 20564088 Free PMC article.

10

Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort.

Müller CB, de Barros RL, Castro MA, Lopes FM, Meurer RT, Roehe A, Mazzini G, Ulbrich-Kulczynski JM, Dal-Pizzol F, Fernandes MC, Moreira JC, Xavier LL, Klamt F. Müller CB, et al. Among authors: lopes fm. J Cancer Res Clin Oncol. 2011 Sep;137(9):1309-16. doi: 10.1007/s00432-011-1001-5. Epub 2011 Jul 8. J Cancer Res Clin Oncol. 2011. PMID: 21735353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page